Nicolet Advisory Services’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $567K | Buy |
15,097
+813
| +6% | +$30.5K | 0.05% | 199 |
|
|
2025
Q1 | $480K | Buy |
14,284
+2,607
| +22% | +$87.6K | 0.05% | 195 |
|
|
2024
Q4 | $386K | Sell |
11,677
-1,538
| -12% | -$50.9K | 0.04% | 245 |
|
|
2024
Q3 | $507K | Buy |
13,215
+430
| +3% | +$16.5K | 0.05% | 200 |
|
|
2024
Q2 | $493K | Buy |
12,785
+795
| +7% | +$30.7K | 0.05% | 200 |
|
|
2024
Q1 | $490K | Sell |
11,990
-124
| -1% | -$5.07K | 0.05% | 179 |
|
|
2023
Q4 | $475K | Sell |
12,114
-1,920
| -14% | -$75.3K | 0.05% | 171 |
|
|
2023
Q3 | $506K | Buy |
14,034
+4,537
| +48% | +$164K | 0.06% | 156 |
|
|
2023
Q2 | $324K | Buy |
9,497
+1,644
| +21% | +$56K | 0.04% | 213 |
|
|
2023
Q1 | $298K | Buy |
+7,853
| New | +$298K | 0.03% | 212 |
|